SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-440494
Filing Date
2013-11-14
Accepted
2013-11-13 18:12:27
Documents
9
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d599924d10q.htm 10-Q 534079
2 EX-31.1 d599924dex311.htm EX-31.1 7355
3 EX-32.1 d599924dex321.htm EX-32.1 4830
  Complete submission text file 0001193125-13-440494.txt   3815320

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rgls-20130930.xml EX-101.INS 489091
5 XBRL TAXONOMY EXTENSION SCHEMA rgls-20130930.xsd EX-101.SCH 35568
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgls-20130930_cal.xml EX-101.CAL 45073
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgls-20130930_def.xml EX-101.DEF 226892
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgls-20130930_lab.xml EX-101.LAB 317628
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgls-20130930_pre.xml EX-101.PRE 261998
Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35670 | Film No.: 131215998
SIC: 2834 Pharmaceutical Preparations